技術(shù)外包服務(wù):

★磷酸化SH2結(jié)構(gòu)含磷酸肌醇SHIP1抗體費(fèi)用 分子生物學(xué)：質(zhì)粒抽提、PCR、Q-PCR、RT-PCR、分子生物學(xué)：基因合成、引物合成、基因測序、載體構(gòu)建等

★蛋白工程：原核、哺乳動物蛋白表達(dá)系統(tǒng)等

★病毒包裝：腺病毒、慢病毒等

★抗體工程：磁珠分選、病理染色、WB、ELISA、IP、IF、IHC、FACS、Confocal等等

★細(xì)胞工程：細(xì)胞表型分析(凋亡、增殖、周期、遷移、侵襲、修復(fù)、克隆形成)、細(xì)胞培養(yǎng)、細(xì)胞膜制備、穩(wěn)定細(xì)胞株構(gòu)建、細(xì)胞RNAi技術(shù)等等。

實(shí)驗(yàn)流程：

磷酸化SH2結(jié)構(gòu)含磷酸肌醇SHIP1抗體費(fèi)用 英文名稱  Anti-Phospho-SHIP1 (Tyr1020)

中文名稱  磷酸化SH2結(jié)構(gòu)含磷酸肌醇SHIP1抗體費(fèi)用 

別    名 P-SHIP1 (Tyr1020); Inositol polyphosphate 5 phosphatase of 145kDa; 4; 5-trisphosphate 5-phosphatase 1; hp51CN; hSHIP; Inositol polyphosphate 5 phosphatase 145kDa; Inositol polyphosphate 5 phosphatase; Inositol polyphosphate 5 phosphatase D; Inositol polyphosphate-5-phosphatase of 145 kDa; INPP 5D; INPP5D; INPP5D protein; MGC104855; MGC142140; MGC142142; p150 ship; p150Ship; Phosphatidylinositol 3,4,5 trisphosphate 5 phosphatase 1; Phosphatidylinositol-3; SH2 containing inositol 5 phosphatase; SH2 containing inositol phosphatase isoform b; SH2 domain containing inositol 5' phosphatase 1; SH2 domain containing inositol phosphatase 1; SH2 domain-containing inositol phosphatase 1; SH2 domain-containing inositol-5''-phosphatase 1; SHIP 1; SHIP-1; SHIP1; SHIP1_RAT; Signaling inositol polyphosphate 5 phosphatase SIP 145; Signaling inositol polyphosphate 5 phosphatase SIP145; SIP 145; SIP-145; SIP145.

產(chǎn)品屬性：

濃    度  1mg/1ml

規(guī) 格  0.1ml/100μg

抗體來源  Rabbit

克隆類型   polyclonal

交叉反應(yīng)   Human, Mouse, Rat, Dog, Cow

產(chǎn)品類型   一抗 磷酸化抗體  

研究領(lǐng)域    免疫學(xué) 信號轉(zhuǎn)導(dǎo) 激酶和磷酸酶 t-淋巴細(xì)胞

蛋白分子量  predicted molecular weight: 134kDa 

性    狀   Lyophilized or Liquid

免 疫 原  KLH conjugated Synthesised phosphopeptide derived from rat SHIP1 around the phosphorylation site of Tyr1020

亞    型  IgG

純化方法   affinity purified by Protein A

儲 存 液   0.01M PBS, pH 7.4 with 10 mg/ml BSA and 0.1% Sodium azide

磷酸化SH2結(jié)構(gòu)含磷酸肌醇SHIP1抗體費(fèi)用 產(chǎn)品應(yīng)用   WB=1:100-500 ELISA=1:500-1000 IP=1:20-100 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500

（石蠟切片需做抗原修復(fù)） 

 not yet tested in other applications.

 optimal dilutions/concentrations should be determined by the end user.  

保存條件  Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C. 

Important Note  This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. 

產(chǎn)品介紹 SHIP1 is a member of the inositol polyphosphate-5-phosphatase (INPP5) family and contains an N-terminal SH2 domain, an inositol phosphatase domain, and two C-terminal protein interaction domains. Expression of this protein is restricted to hematopoietic cells where its movement from the cytosol to the plasma membrane is mediated by tyrosine phosphorylation in response to multiple cytokine and B and T cell receptor activation. At the plasma membrane, the protein hydrolyzes the 5' phosphate from phosphatidylinositol (3,4,5)-trisphosphate and inositol-1,3,4,5-tetrakisphosphate, thereby affecting multiple signaling pathways. Overall the protein functions as a negative regulator of myeliod cell proliferation and survival.

Function : Phosphatidylinositol (PtdIns) phosphatase that specifically hydrolyzes the 5-phosphate of phosphatidylinositol-3,4,5-trisphosphate (PtdIns(3,4,5)P3) to produce PtdIns(3,4)P2, thereby negatively regulating the PI3K (phosphoinositide 3-kinase) pathways. Acts as a negative regulator of B-cell antigen receptor signaling. Mediates signaling from the FC-gamma-RIIB receptor (FCGR2B), playing a central role in terminating signal transduction from activating immune/hematopoietic cell receptor systems. Acts as a negative regulator of myeloid cell proliferation/survival and chemotaxis, mast cell degranulation, immune cells homeostasis, integrin alpha-IIb/beta-3 signaling in platelets and JNK signaling in B-cells. Regulates proliferation of osteoclast precursors, macrophage programming, phagocytosis and activation and is required for endotoxin tolerance. Involved in the control of cell-cell junctions, CD32a signaling in neutrophils and modulation of EGF-induced phospholipase C activity. Key regulator of neutrophil migration, by governing the formation of the leading edge and polarization required for chemotaxis. Modulates FCGR3/CD16-mediated cytotoxicity in NK cells. Mediates the activin/TGF-beta-induced apoptosis through its Smad-dependent expression. May also hydrolyze PtdIns(1,3,4,5)P4, and could thus affect the levels of the higher inositol polyphosphates like InsP6 (By similarity).

Subunit : Interacts with tyrosine phosphorylated forms of SHC1, DOK1, DOK3, PTPN11/SHP-2, SLAMF1/CD150. Interacts with PTPN11 in response to IL-3. Interacts with receptors EPOR, MS4A2/FCER1B and FCER1G, FCGR2A, FCGR2B and FCGR3. Interacts with GRB2 and PLCG1. Interacts with tyrosine kinases SRC and TEC. Interacts with FCGR2A, leading to regulate gene expression during the phagocytic process. Interacts with c-Met/MET (By similarity). Interacts with MILR1 (tyrosine-phosphorylated). Can weakly interact (via NPXY motif 2) with DAB2 (via PID domain); the interaction is impaired by tyrosine phosphorylation of the NPXY motif.

Subcellular Location : Cytoplasm (By similarity). Membrane; Peripheral membrane protein (By similarity). Note=Translocates to the plasma membrane when activated, translocation is probably due to different mechanisms depending on the stimulus and cell type. Partly translocated via its SH2 domain which mediates interaction with tyrosine phosphorylated receptors such as the FC-gamma-RIIB receptor (FCGR2B) or CD16/FCGR3. Tyrosine phosphorylation may also participate in membrane localization (By similarity).

Tissue Specificity : Specifically expressed in immune and hematopoietic cells. Expressed in bone marrow and blood cells.

Post-translational modifications : Tyrosine phosphorylated by the members of the SRC family after exposure to a diverse array of extracellular stimuli such as cytokines, growth factors, antibodies, chemokines, integrin ligands and hypertonic and oxidative stress. Phosphorylated upon IgG receptor FCGR2B-binding.

Similarity : Belongs to the inositol-1,4,5-trisphosphate 5-phosphatase family.

Contains 1 SH2 domain.

Database links : UniProtKB/Swiss-Prot: P97573.1

全、新、優(yōu)、品、好四大特點(diǎn)：

磷酸化SH2結(jié)構(gòu)含磷酸肌醇SHIP1抗體費(fèi)用 全：公司提供上萬種產(chǎn)品，涵蓋了生物試劑，elisa試劑盒，標(biāo)準(zhǔn)品，培養(yǎng)基，原裝耗材，抗體、培養(yǎng)基、ATCC細(xì)胞等，基本上各種科研所需產(chǎn)品在我司都能找到。

新：產(chǎn)品更新速度較快，基本上每周都有新產(chǎn)品出現(xiàn)。

優(yōu)：產(chǎn)品質(zhì)量好，投訴比較少。

好：我公司具有優(yōu)質(zhì)的技術(shù)團(tuán)隊(duì)，產(chǎn)品一旦售出，實(shí)驗(yàn)過程中遇到困難可提供在線技術(shù)咨詢。使您使用產(chǎn)品時(shí)沒有任何的后顧之憂。

正在熱銷的相關(guān)產(chǎn)品：

Anti-TM/Biotin 生物素化調(diào)節(jié)蛋白抗體IgGMulti-class antibodies規(guī)格： 0.2ml

BAFF/CD257(B cell activating factor) TNF家族B細(xì)胞激活因子抗原Multi-class antibodies規(guī)格： 0.5mg

硫酯包含蛋白-1抗體 Anti-Thioster-containing protein 1 1ml

SMARCA2 英文名稱： ATP依賴解旋酶SMARCA2抗體 0.2ml

EGFL7 英文名稱： 類表皮生長因子域7抗體 0.1ml

Rhesus antibody Rh Phospho-LAT (Tyr171) 磷酸化T細(xì)胞活化連接蛋白抗體 規(guī)格 0.1ml

BAFF/CD257(B cell activating factor) TNF家族B細(xì)胞激活因子抗原Multi-class antibodies規(guī)格： 0.5mg

Anti-PDGF-BB/FITC 熒光素標(biāo)記血小板源性生長因子-BB抗體IgGMulti-class antibodies規(guī)格： 0.2ml

Rabbit Anti- guinea pig IgM/FITC 熒光素標(biāo)記兔抗豚鼠IgMMulti-class antibodies規(guī)格： 0.3ml

死亡受體4抗體 Anti-DR4/APO2/TRAILR1 0.1ml

Rabbit Anti-horse IgM/PE-CY5 PE-CY5標(biāo)記的兔抗馬IgM 0.1ml

FBXO7 英文名稱： F-box蛋白家族FBXO7抗體 0.2ml

Rhesus antibody Rh Phospho-Torc1/Crtc1 (Ser151) 磷酸化CREB轉(zhuǎn)錄共激活因子TORC1抗體 規(guī)格 0.1ml

Rabbit Anti- guinea pig IgM/FITC 熒光素標(biāo)記兔抗豚鼠IgMMulti-class antibodies規(guī)格： 0.3ml

SIP1 peptide 運(yùn)動神經(jīng)元存活蛋白結(jié)合蛋白1抗原Multi-class antibodies規(guī)格： 0.5mg

Anti-Bim 細(xì)胞死亡調(diào)解子抗體Multi-class antibodies規(guī)格： 0.2ml

Rhesus antibody Rh PGGT1A/FNTA 蛋白香葉烯基轉(zhuǎn)移酶1α抗體 規(guī)格 0.2ml

Flt-1/VEGFR1 濃縮液 0.1ml 進(jìn)口分裝

Urocortin 3 英文名稱： 尿皮質(zhì)素UCN3抗體 0.1ml

CCL24 英文名稱： 嗜酸粒細(xì)胞趨化蛋白24抗體 0.2ml

Anti-Bim 細(xì)胞死亡調(diào)解子抗體Multi-class antibodies規(guī)格： 0.2ml

IL6 Protein Cynomolgus 重組食蟹猴 / 恒河猴 IL6 / Ierleukin-6 蛋白

小鼠肝動脈平滑肌細(xì)胞完全培養(yǎng)基 100mL

CTSZ Others Human 人 CTSZ 人細(xì)胞裂解液 (陽性對照)

K7M2 wt [K7M2-WT]小鼠成骨細(xì)胞 K7M2 wt [K7M2-WT] murine osteosarcoma cells DMEM培養(yǎng)基+10%FBS

CL-0143Lncap clone FGC(人細(xì)胞)5×106cells/瓶×2

RL1(大鼠肺成纖維樣細(xì)胞) 5×106cells/瓶×2 JAR(胚絨毛癌細(xì)胞)

CM-M097小鼠皮下脂肪細(xì)胞完全培養(yǎng)基100mL

NGF Others Human 人 β-NGF / Beta-NGF CHO細(xì)胞裂解液 (陽性對照)

角膜上皮細(xì)胞培養(yǎng)基CEpiCM-prf

婆羅門牛皮膚成纖維樣細(xì)胞;BOS-4 原髓細(xì)胞，HL-60細(xì)胞 Dami(巨核細(xì)胞細(xì)胞)

EB病毒轉(zhuǎn)化的人B淋巴細(xì)胞;KMY0901

BAMBI Others Human 人 BAMBI / NMA 人細(xì)胞裂解液 (陽性對照)

磷酸化SH2結(jié)構(gòu)含磷酸肌醇SHIP1抗體費(fèi)用 IL6 Protein Cynomolgus 重組食蟹猴 / 恒河猴 IL6 / Ierleukin-6 蛋白

小鼠肝動脈平滑肌細(xì)胞完全培養(yǎng)基 100mL

CTSZ Others Human 人 CTSZ 人細(xì)胞裂解液 (陽性對照)

K7M2 wt [K7M2-WT]小鼠成骨細(xì)胞 K7M2 wt [K7M2-WT] murine osteosarcoma cells DMEM培養(yǎng)基+10%FBS

CL-0143Lncap clone FGC(人細(xì)胞)5×106cells/瓶×2

RL1(大鼠肺成纖維樣細(xì)胞) 5×106cells/瓶×2 JAR(胚絨毛癌細(xì)胞)